Y-mAbs Therapeutics, Inc. (YMAB)
USD 4.93
(2.07%)
USD 4.93
(2.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 73.4 Million USD | 27.21% |
| 2022 | 57.7 Million USD | 78.18% |
| 2021 | 32.38 Million USD | 74.6% |
| 2020 | 18.54 Million USD | 11272.89% |
| 2019 | -166 Thousand USD | -472.41% |
| 2018 | -29 Thousand USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 17.78 Million USD | -16.6% |
| 2024 Q2 | 19.78 Million USD | 11.25% |
| 2023 Q1 | 18.16 Million USD | -38.26% |
| 2023 Q2 | 16.1 Million USD | -11.37% |
| 2023 FY | 73.4 Million USD | 27.21% |
| 2023 Q4 | 21.32 Million USD | 19.74% |
| 2023 Q3 | 17.8 Million USD | 10.6% |
| 2022 Q2 | 9.55 Million USD | 10.42% |
| 2022 Q4 | 29.42 Million USD | 192.46% |
| 2022 Q3 | 10.06 Million USD | 5.28% |
| 2022 Q1 | 8.65 Million USD | 6.37% |
| 2022 FY | 57.7 Million USD | 78.18% |
| 2021 Q2 | 10.54 Million USD | 99.26% |
| 2021 FY | 32.38 Million USD | 74.6% |
| 2021 Q3 | 8.41 Million USD | -20.17% |
| 2021 Q4 | 8.13 Million USD | -3.3% |
| 2021 Q1 | 5.29 Million USD | -71.48% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 18.54 Million USD | 11272.89% |
| 2020 Q4 | 18.54 Million USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | -166 Thousand USD | -472.41% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | -29 Thousand USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | 47.425% |
| Immix Biopharma, Inc. | -5468.00 USD | 1342510.388% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 11154.669% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 194.594% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 14028.463% |
| MiMedx Group, Inc. | 266.84 Million USD | 72.492% |
| Novavax, Inc. | 639.93 Million USD | 88.53% |
| Seer, Inc. | 7.02 Million USD | -944.585% |
| Acelyrin, Inc. | -115 Thousand USD | 63928.696% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 45.736% |
| IO Biotech, Inc. | -756 Thousand USD | 9809.392% |
| Ardelyx, Inc. | 106.66 Million USD | 31.181% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 175.712% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 335.51% |
| Fortress Biotech, Inc. | 57.85 Million USD | -26.878% |
| Fortress Biotech, Inc. | 57.85 Million USD | -26.878% |
| Geron Corporation | -123.5 Million USD | 159.434% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 69.509% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -342.8% |
| Incyte Corporation | 3.44 Billion USD | 97.867% |
| Innoviva, Inc. | 261.06 Million USD | 71.883% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 133560.0% |
| ChromaDex Corporation | 50.78 Million USD | -44.551% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 38.705% |
| MEI Pharma, Inc. | 49.32 Million USD | -48.809% |
| NextCure, Inc. | -3.68 Million USD | 2092.481% |
| Onconetix, Inc. | -1.12 Million USD | 6612.179% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 353.393% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 51322.95% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 169.168% |
| Vaxcyte, Inc. | -75 Million USD | 197.871% |
| Precigen, Inc. | 106 Thousand USD | -69148.113% |
| Pharming Group N.V. | 220.1 Million USD | 66.651% |
| ContextLogic Inc. | 59 Million USD | -24.412% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 31739.224% |
| Pyxis Oncology, Inc. | -2 Million USD | 3770.15% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 33.131% |
| AlloVir, Inc. | -398 Thousand USD | 18542.965% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -152.635% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 730405.442% |
| Summit Therapeutics Inc. | -2.05 Million USD | 3680.634% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 611791.667% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 12955.166% |
| Senti Biosciences, Inc. | -2.68 Million USD | 2835.855% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -61069.167% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 1629.867% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -151.993% |
| Psyence Biomedical Ltd. | -240.00 USD | 30584683.333% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 166215.235% |
| Chimerix, Inc. | 324 Thousand USD | -22555.247% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 128144.866% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 89615.854% |
| CRISPR Therapeutics AG | 240.95 Million USD | 69.537% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 29.487% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -14153.01% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -7174.827% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 2088.164% |
| Precision BioSciences, Inc. | 40.47 Million USD | -81.367% |
| Dyadic International, Inc. | 922.95 Thousand USD | -7853.025% |
| Elevation Oncology, Inc. | -39 Thousand USD | 188312.821% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -248.526% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 39.072% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 95.164% |
| Aptorum Group Limited | -1.11 Million USD | 6685.071% |
| Bicycle Therapeutics plc | -129.52 Million USD | 156.673% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 1962.052% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -832.575% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 649.512% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 94.66% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -1576.633% |
| Jaguar Health, Inc. | 7.72 Million USD | -850.324% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -14698.992% |
| AbCellera Biologics Inc. | 38.02 Million USD | -93.039% |
| PureTech Health plc | -1.6 Million USD | 4679.102% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 14304.851% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 261.948% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -9052.494% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -240.696% |
| AnaptysBio, Inc. | 14.78 Million USD | -396.604% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 420.271% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 62048.165% |
| Molecular Templates, Inc. | 50.39 Million USD | -45.655% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -149.781% |
| Vaxxinity, Inc. | -2.23 Million USD | 3385.721% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 15019.309% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 433.847% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 256.713% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 7833.356% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1468160.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -1711.972% |
| ImmuCell Corporation | 4.39 Million USD | -1569.66% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 42082.235% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -17212.028% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -285.459% |
| Opthea Limited | 21.72 Thousand USD | -337851.197% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 140.463% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 174.736% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 174.777% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -11953.038% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 76.599% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -2751.709% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 144764.959% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1134.136% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 15568.08% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 705898.077% |
| Soligenix, Inc. | 97.31 Thousand USD | -75331.349% |
| Century Therapeutics, Inc. | -10.8 Million USD | 779.091% |
| Kura Oncology, Inc. | -849 Thousand USD | 8745.819% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 209.387% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 50034.014% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 25.885% |
| Autolus Therapeutics plc | -4.86 Million USD | 1608.178% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -77.362% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 43792.262% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 22.508% |
| GRI Bio, Inc. | 10.84 Million USD | -577.087% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -2789.898% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 944.975% |
| IGM Biosciences, Inc. | -211.66 Million USD | 134.68% |
| INmune Bio, Inc. | 155 Thousand USD | -47256.774% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -18.509% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 4973.096% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 11419.693% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 250844.688% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -18159.453% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 3777.505% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 23551.438% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 22.293% |
| Verastem, Inc. | -62 Thousand USD | 118491.935% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -2914.497% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 28223.755% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -2324.942% |
| Histogen Inc. | 3.76 Million USD | -1847.546% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -12639.617% |
| Surrozen, Inc. | -27.23 Million USD | 369.567% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1462.089% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 6192.142% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 386.205% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -266.063% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 3707322.222% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1109.988% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 109442.927% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 52.579% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -50244.993% |
| Apollomics, Inc. | 127 Thousand USD | -57697.638% |
| Amarin Corporation plc | 165.54 Million USD | 55.659% |
| Mesoblast Limited | -9.81 Million USD | 847.866% |
| Turnstone Biologics Corp. | 16.5 Million USD | -344.705% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 166.435% |
| Synaptogenix, Inc. | -6347.00 USD | 1156599.133% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 144027.451% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 54.511% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 95.824% |
| Better Therapeutics, Inc. | -2.72 Million USD | 2789.74% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 165.444% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 78.288% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 643534.432% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1272.572% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 6724.819% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -903.047% |
| Insmed Incorporated | 239.63 Million USD | 69.369% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -1951.509% |
| OmniAb, Inc. | 14.66 Million USD | -400.464% |
| Alector, Inc. | -95.05 Million USD | 177.223% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 41.568% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 268.886% |
| Zai Lab Limited | 170.9 Million USD | 57.05% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 10.35% |
| Aura Biosciences, Inc. | -1.29 Million USD | 5768.185% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -56363.846% |
| Immunic, Inc. | -111 Thousand USD | 66228.829% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -362.994% |
| Veracyte, Inc. | 248.14 Million USD | 70.42% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.05% |
| FibroGen, Inc. | 128.9 Million USD | 43.056% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 13014816.312% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 729.157% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 97.84% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -18769.666% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 79.343% |
| TG Therapeutics, Inc. | 219.1 Million USD | 66.499% |
| Galecto, Inc. | -830 Thousand USD | 8943.735% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 5399.856% |
| Fortrea Holdings Inc. | 424 Million USD | 82.688% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 185.187% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 13045.855% |
| XBiotech Inc. | -1.74 Million USD | 4308.888% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 6724.819% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 257.954% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 197.179% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -336.845% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 81.132% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 247.85% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 77.535% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 748.216% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -200.204% |
| NexImmune, Inc. | -1.02 Million USD | 7261.464% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -1359214.815% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1133.022% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.35% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 109940.334% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 2167.108% |
| Ainos, Inc. | -253.73 Thousand USD | 29029.229% |
| Pluri Inc. | 322 Thousand USD | -22695.963% |
| Prothena Corporation plc | -129.2 Million USD | 156.813% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -45.572% |
| Celularity Inc. | 6.75 Million USD | -986.647% |
| Rallybio Corporation | -150 Thousand USD | 49035.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 325.114% |
| MeiraGTx Holdings plc | 287 Thousand USD | -25475.958% |
| Omeros Corporation | -69.77 Million USD | 205.194% |
| Humacyte, Inc. | -76.55 Million USD | 195.889% |
| Immunocore Holdings plc | 248.39 Million USD | 70.449% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 583.901% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -17.667% |
| Blueprint Medicines Corporation | 236.58 Million USD | 68.974% |
| CalciMedica, Inc. | -58 Thousand USD | 126656.897% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 5247.475% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 2680.977% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 337.82% |
| Pulmatrix, Inc. | -8.22 Million USD | 992.981% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 6373.761% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 18496.742% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 118.406% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -2544.596% |
| Cytokinetics, Incorporated | -322.59 Million USD | 122.754% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -8414.392% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 21625.806% |
| Vor Biopharma Inc. | -3.49 Million USD | 2202.033% |
| Roivant Sciences Ltd. | 109.23 Million USD | 32.803% |
| Evogene Ltd. | 1.39 Million USD | -5146.819% |
| ProKidney Corp. | -3.16 Million USD | 2416.283% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 267.159% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -970.483% |
| CorMedix Inc. | -205.56 Thousand USD | 35808.448% |
| BioLineRx Ltd. | 1.1 Million USD | -6524.819% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 193.304% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 222533.333% |
| Atai Life Sciences N.V. | -5000.00 USD | 1468160.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 60336.01% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 76561.458% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 5384.593% |
| Sagimet Biosciences Inc. | 2 Million USD | -3570.15% |
| MediciNova, Inc. | 979.7 Thousand USD | -7392.357% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 187.054% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 77729.951% |
| GeoVax Labs, Inc. | -20.72 Million USD | 454.248% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 69.983% |
| Biomea Fusion, Inc. | -4.2 Million USD | 1847.274% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 91.585% |
| Mereo BioPharma Group plc | 7.42 Million USD | -888.459% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 23778.387% |
| Absci Corporation | -41.84 Million USD | 275.4% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1468160.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 196.111% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 3082.649% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 65.657% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 7900.531% |
| Allakos Inc. | -6.14 Million USD | 1295.294% |
| Imunon, Inc. | -720 Thousand USD | 10294.79% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 206.387% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 84.576% |
| BioAtla, Inc. | -103.73 Million USD | 170.763% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 643534.432% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 41337.64% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 130.23% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 23702.251% |
| XOMA Corporation | 3.86 Million USD | -1801.14% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 204.734% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -396.167% |
| aTyr Pharma, Inc. | -2.38 Million USD | 3173.827% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -489.109% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 253213.793% |
| Viridian Therapeutics, Inc. | -1 Million USD | 7382.044% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -564638361.538% |
| Akari Therapeutics, Plc | -4000.00 USD | 1835175.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 88.475% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -37599.016% |
| UroGen Pharma Ltd. | 73.35 Million USD | -0.07% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 374.979% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -632139.449% |
| Orgenesis Inc. | -5.72 Million USD | 1382.148% |
| Entera Bio Ltd. | -56 Thousand USD | 131176.786% |
| GH Research PLC | -315 Thousand USD | 23402.54% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 38937.566% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 14081.524% |
| Xencor, Inc. | -85.26 Million USD | 186.093% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 33317.484% |
| Replimune Group, Inc. | -2.65 Million USD | 2864.708% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 7431.239% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 58.726% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -37599.016% |
| Portage Biotech Inc. | -54 Thousand USD | 136031.481% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 77729.951% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 19570.292% |
| OncoCyte Corporation | 413 Thousand USD | -17673.123% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 1633092.214% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 33064514.414% |
| Purple Biotech Ltd. | -196 Thousand USD | 37550.51% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -718.499% |
| scPharmaceuticals Inc. | 9.78 Million USD | -650.388% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 802.76% |
| HilleVax, Inc. | -2.15 Million USD | 3504.592% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 75773.196% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 489322.874% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 11088.473% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 319243.478% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 978003.482% |
| Savara Inc. | -44.26 Million USD | 265.838% |
| Curis, Inc. | 9.81 Million USD | -648.17% |
| Daré Bioscience, Inc. | 2.76 Million USD | -2550.385% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 58922.162% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 4345.402% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 32294.298% |
| BeiGene, Ltd. | 2.07 Billion USD | 96.469% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 2725.38% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 118.366% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -29.486% |
| Erasca, Inc. | -3.73 Million USD | 2066.854% |
| bluebird bio, Inc. | -4.03 Million USD | 1921.414% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 260228.287% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 96.146% |
| DBV Technologies S.A. | 15.72 Million USD | -366.703% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 260228.287% |
| Moderna, Inc. | 2.15 Billion USD | 96.594% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 8122.186% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -816.85% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 13794.59% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 45.135% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1279.733% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 286.572% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 166.053% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 2145.792% |
| MacroGenics, Inc. | 50.52 Million USD | -45.275% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1303.723% |
| Prime Medicine, Inc. | -147.9 Million USD | 149.628% |
| Aditxt, Inc. | -111.66 Thousand USD | 65837.955% |
| Adagene Inc. | 18.11 Million USD | -305.284% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -14941.598% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 47.645% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 53.494% |
| SciSparc Ltd. | 2.19 Million USD | -3242.577% |
| Vericel Corporation | 135.57 Million USD | 45.858% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 293137.646% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 237021.438% |
| Generation Bio Co. | -73.91 Million USD | 199.313% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 16897.025% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -34.391% |
| Invivyd, Inc. | -2.02 Million USD | 3719.477% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 124.399% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 71063.282% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 23.831% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 25.318% |
| ADMA Biologics, Inc. | 88.21 Million USD | 16.794% |
| Clene Inc. | 533 Thousand USD | -13671.67% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -204.461% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 7770.115% |
| GeoVax Labs, Inc. | -20.72 Million USD | 454.248% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -3592.304% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 37875.067% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -47.381% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1135.011% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 8880.263% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 12.003% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -100298.019% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -38.074% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 142.383% |
| Trevena, Inc. | 1.45 Million USD | -4944.88% |
| Surrozen, Inc. | -27.23 Million USD | 369.567% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 20894.051% |
| Cingulate Inc. | -582.91 Thousand USD | 12692.337% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 236883.871% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 472.623% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 969756.539% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 8431.782% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 89.217% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 7529.453% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 130381.14% |
| Kronos Bio, Inc. | 1.37 Million USD | -5250.073% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 236.777% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 25238.014% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 15131.926% |
| ImmunityBio, Inc. | -17.89 Million USD | 510.302% |
| Korro Bio, Inc. | -3.63 Million USD | 2122.121% |
| Kineta, Inc. | 5.43 Million USD | -1251.058% |
| BioVie Inc. | -229.37 Thousand USD | 32101.029% |
| Codexis, Inc. | 57.33 Million USD | -28.027% |
| Celularity Inc. | 6.75 Million USD | -986.647% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -1729.13% |
| Celcuity Inc. | -142.77 Thousand USD | 51512.742% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -144993.892% |
| Cibus, Inc. | 1.42 Million USD | -5061.955% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 19726.471% |
| IN8bio, Inc. | -2.5 Million USD | 3034.946% |
| Kodiak Sciences Inc. | -25.94 Million USD | 382.896% |
| Annexon, Inc. | -3.26 Million USD | 2346.801% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 3691.145% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 275.87% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -11369.219% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 90.571% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 57.559% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 3963.316% |
| Arcellx, Inc. | 108.27 Million USD | 32.209% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 326.769% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 7.324% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 447.026% |
| Moolec Science SA | -143.3 Thousand USD | 51321.521% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 273.456% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -2133.131% |
| Royalty Pharma plc | 1.79 Billion USD | 95.908% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 204.727% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 2032298.228% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -31622.496% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 165.883% |
| Humacyte, Inc. | -76.55 Million USD | 195.889% |
| 89bio, Inc. | -273 Thousand USD | 26987.546% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 5939.539% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 8756.014% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 59777.236% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -6459.696% |
| Notable Labs, Ltd. | 113 Thousand USD | -64858.407% |
| Liquidia Corporation | 14.6 Million USD | -402.76% |
| Mustang Bio, Inc. | -2.22 Million USD | 3399.011% |
| Immunovant, Inc. | -231 Thousand USD | 31876.19% |
| Quantum-Si incorporated | 488 Thousand USD | -14941.598% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 232.117% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 244776.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -3842.159% |
| Acasti Pharma Inc. | -11 Thousand USD | 667400.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 35973.363% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 11419.693% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 143.82% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -6369.619% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 19365.879% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 3848.876% |
| PepGen Inc. | -1.18 Million USD | 6299.578% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 57897.638% |
| United Therapeutics Corporation | 2.07 Billion USD | 96.454% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 420.579% |
| Solid Biosciences Inc. | -76.56 Million USD | 195.873% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 88983.911% |
| Immuneering Corporation | -764.13 Thousand USD | 9705.987% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -110673.572% |
| Belite Bio, Inc | -399 Thousand USD | 18496.742% |
| XOMA Corporation | 3.86 Million USD | -1801.14% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 466.356% |
| Bionomics Limited | -434.44 Thousand USD | 16995.654% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 6934.544% |
| uniQure N.V. | 2.21 Million USD | -3213.905% |
| Cassava Sciences, Inc. | -89.42 Million USD | 182.085% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 179.726% |
| Forte Biosciences, Inc. | -9000.00 USD | 815688.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 8890.778% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 16897.025% |
| Altimmune, Inc. | -65.37 Million USD | 212.283% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 79.725% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 6934.544% |
| Compugen Ltd. | 31.45 Million USD | -133.359% |
| Peak Bio, Inc. | 367.76 Thousand USD | -19858.996% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -199.409% |
| Benitec Biopharma Inc. | 108 Thousand USD | -67865.741% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 94206.41% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 6201.663% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 4128.705% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 61783.193% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 6201.663% |
| Instil Bio, Inc. | -4.75 Million USD | 1643.377% |
| argenx SE | 1.1 Billion USD | 93.378% |
| Immunome, Inc. | -8.9 Million USD | 924.105% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 3983.757% |
| Verona Pharma plc | -679.62 Thousand USD | 10900.531% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 42044.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 3177.694% |
| CervoMed Inc. | -1.29 Million USD | 5774.201% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 3149.564% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 1636.592% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -2870.579% |
| Moolec Science SA | -143.3 Thousand USD | 51321.521% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 18089.609% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 2847.604% |
| Design Therapeutics, Inc. | -537 Thousand USD | 13769.088% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 17290.398% |
| NeurAxis, Inc. | 2.15 Million USD | -3303.48% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -3320.457% |
| Lumos Pharma, Inc. | 2 Million USD | -3557.349% |
| Achilles Therapeutics plc | -4.73 Million USD | 1651.445% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 42044.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 69561.084% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -131.857% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -8414.392% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 7212.694% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 261.155% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -170604.651% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 9029.805% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 557958.337% |
| Palisade Bio, Inc. | 246 Thousand USD | -29738.618% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 222533.333% |
| Beam Therapeutics Inc. | -59.67 Million USD | 223.011% |
| Neurogene Inc. | -3.26 Million USD | 2350.245% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 47.319% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -83.508% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 24814.815% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 1922.755% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 867.332% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -421.328% |
| Athira Pharma, Inc. | -969 Thousand USD | 7675.129% |
| Vaccinex, Inc. | -16 Million USD | 558.654% |
| HCW Biologics Inc. | -574.82 Thousand USD | 12869.648% |
| XOMA Corporation | 3.86 Million USD | -1801.14% |
| Nektar Therapeutics | 53.47 Million USD | -37.258% |
| Arvinas, Inc. | 71.8 Million USD | -2.233% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 187.949% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 216.93% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 22895.963% |
| Rezolute, Inc. | -36 Thousand USD | 203997.222% |
| Clene Inc. | 533 Thousand USD | -13671.67% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 5716844.548% |
| BeyondSpring Inc. | 1.75 Million USD | -4092.062% |
| Synlogic, Inc. | -1.92 Million USD | 3915.125% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 198486.486% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1259.239% |
| Peak Bio, Inc. | 367.76 Thousand USD | -19858.996% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 487.085% |
| Krystal Biotech, Inc. | 47.6 Million USD | -54.192% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 47.975% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -1360.756% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 2934.948% |
| MannKind Corporation | 136.19 Million USD | 46.103% |
| Ikena Oncology, Inc. | -50.49 Million USD | 245.376% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 32.543% |
| Gossamer Bio, Inc. | -4.38 Million USD | 1773.957% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 29228.175% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1468160.0% |
| Legend Biotech Corporation | 140.92 Million USD | 47.915% |
| Mural Oncology plc | -2.56 Million USD | 2959.486% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 13421.779% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 73503.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -253.681% |
| REGENXBIO Inc. | 53.02 Million USD | -38.42% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1470.238% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 38256.205% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 4338.048% |
| Vaxart, Inc. | -60.76 Million USD | 220.802% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 28033.252% |
| Cellectis S.A. | 18 Thousand USD | -407694.444% |
| Longeveron Inc. | 221 Thousand USD | -33114.027% |
| Repare Therapeutics Inc. | -80.07 Million USD | 191.674% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 93.284% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 5772.566% |
| Revolution Medicines, Inc. | -399.66 Million USD | 118.366% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 209822.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -149702.041% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.147% |
| Denali Therapeutics Inc. | -93.34 Million USD | 178.636% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 293137.646% |
| Veru Inc. | 7.56 Million USD | -870.178% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 48711.258% |
| Cingulate Inc. | -582.91 Thousand USD | 12692.337% |
| Passage Bio, Inc. | -3.72 Million USD | 2072.669% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 609556.991% |
| Exicure, Inc. | -1.42 Million USD | 5258.327% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 19265.274% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -2615.612% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 14417.648% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -7.746% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 49163.881% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 223.979% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -18673.146% |
| OmniAb, Inc. | 14.66 Million USD | -400.464% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -267.144% |
| Lipocine Inc. | -2.85 Million USD | 2674.805% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 4082.8% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1386.643% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 4973.096% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 2.54% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 113027.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 12.922% |
| Ocugen, Inc. | -33.53 Million USD | 318.872% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 2421.41% |
| Q32 Bio Inc. | 578 Thousand USD | -12599.481% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 27799.245% |
| Alumis Inc. Common Stock | -1.28 Million USD | 5816.745% |
| Equillium, Inc. | 35.95 Million USD | -104.135% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 4400.117% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -14560.691% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 1775692.646% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 28440.927% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -17264.778% |
| Dominari Holdings Inc. | 2.03 Million USD | -3499.951% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 40107.958% |
| vTv Therapeutics Inc. | -13.59 Million USD | 639.926% |
| Bio-Techne Corporation | 773.07 Million USD | 90.505% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -323.829% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 84.07% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 6379.127% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 406.101% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -527.537% |
| Nkarta, Inc. | -5.86 Million USD | 1350.69% |
| BioCardia, Inc. | -7.24 Million USD | 1112.595% |
| Iterum Therapeutics plc | -1.75 Million USD | 4294.457% |